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ABSTRACT 
 
Anterior gradient homolog 2 (AGR2) is a proto-oncogene that encodes a secreted 
protein with biological roles in cell migration, differentiation, and growth, and is also 
implicated in epithelial barrier function and integrity. AGR2 is up-regulated in prostate 
cancer, breast cancer, lung cancer, renal carcinomas and endometrial carcinomas, and it 
contributes to the survival of cells undergoing physiological stress. We previously 
reported that AGR2 expression in the ovine endometrium increased between days 9 and 
12 post-mating, was stimulated by progesterone, and associated with conceptus 
elongation. In situ hybridization studies localized AGR2 mRNA to the luminal 
epithelium (LE) of the ovine endometrium.  Further, AGR2 mRNA expression is greater 
from Days 14 to 16 of pregnancy than in the cycle, suggesting a role for conceptus-
derived products in regulation of AGR2 expression in the endometrium.  Using osmotic 
pumps to infuse pregnancy levels of hormones into the uterus of cyclic ewes, we found 
that interferon tau (IFNT) along with cortisol and prostaglandins (PGE2, PGF2α, and 
PGI2) or both cortisol and prostaglandins increased (P<0.05) expression of AGR2 
mRNA in the endometrium compared to controls receiving vehicle and ewes receiving 
IFNT, cortisol, or prostaglandins alone.  A role for AGR2 in placental function during 
later pregnancy has not been described for any species.  Using a model of maternal 
nutrient restriction, we utilized natural population variance in fetal growth to identify 
novel genes associated with the development of either intrauterine growth restricted 
(IUGR) or non-IUGR pregnancies in sheep.  Interestingly, microarray analysis of 
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placentomes from IUGR and non-IUGR pregnancies at Day 125 of pregnancy found 
AGR2 was up-regulated (P<0.05) in IUGR pregnancies.  Quantitative real-time PCR 
analysis confirmed that AGR2 mRNA was 2.7-fold higher in placentomes from IUGR 
pregnancies. Collectively, results suggest that AGR2 is involved in growth and 
development of the early conceptus. Additionally, elevated AGR2 expression may be 
associated with increased levels of physiological stress in the IUGR pregnancy.  During 
late pregnancy, a reduction in the proliferative actions of AGR2 may be necessary for 
enhanced placental function in the nutritionally restricted ewe.   
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CHAPTER I  
INTRODUCTION 
 
 Previous reports from our laboratory have demonstrated that exogenous 
progesterone treatment advanced blastocyst morphology. The study included ewes being 
bred at Day 0 of estrus and then assigned randomly to receive daily intramuscular 
injections of either corn oil (CO) vehicle as control or 25 mg progesterone per day for 36 
hours post mating to hysterectomy at Day 9 (Study 1). A second study was also 
conducted in which ewes were bred at Day 0 of estrus and assigned randomly to receive 
CO treatment or progesterone treatment through day 12 of gestation. Additionally, a 
third treatment group received daily progesterone injections until day 8 in which they 
then received injections of RU486 (progesterone receptor antagonist) until hysterectomy 
performed on Day 12 (Study 2). It was concluded that injections of P4 beginning on Day 
1.5 after mating increased blastocyst diameter 2.2-fold on Day 9 (Study 1) and 
accelerated the morphological transformation of spherical blastocysts into filamentous 
conceptuses on Day 12 (Study 2)[1]. Microarray analysis was conducted to identify 
differences in the endometrial transcriptome between days 9 and 12 of pregnancy and 
between P4 and CO-treated ewes. Anterior Gradient Homolog 2 (AGR2) was among the 
novel genes present in this microarray. For validation of AGR2, steady-state levels of 
endometrial mRNA was determined by slot blot hybridization analysis. Steady-state 
mRNA levels of AGR2 increased on day 12 versus day 9 (P<0.05), and AGR2 was found 
to a greater degree in ewes treated with progesterone versus those with the corn oil 
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treatment (Figure 1.1). The finding of AGR2 in this study led us to further question the 
role of AGR2 and, in turn, its relevance in ovine pregnancy. 
 
 
 
 
Figure 1.1. Effects of treatment with CO or P4 on endometrial mRNA levels. Steady-
state levels of endometrial mRNAs were determined by slot blot hybridization analysis. 
Data are presented as LSM with SE *Significant effect of treatment (P<0.05). 
 
 
 Further work identified AGR2 as a relevant factor in later pregnancy. It is well 
established that fetal environment correlates to metabolic syndrome. However, 
therapeutic means for treatment of harsh gestational conditions and thus the facilitation 
of nutrient transfer are not established. Understanding nutritional support of embryonic 
and fetal development are critical for both clinicians and animal agriculturalists to ensure 
* 
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enhanced fertility, pregnancy survival, and fetal growth [2]. Inadequate delivery of 
nutrients results in intrauterine growth restriction (IUGR), a leading cause of neonatal 
morbidity and mortality[3, 4]. Because our laboratory has a profound interest in 
understanding gestational stress and subsequently fetal growth retardation, studies were 
performed to evaluate mechanisms by which placental fetal nutrient transfer could be 
supplemented. For example, previous reports from our laboratory have established both 
supplemental arginine and treatment with Viagra to be viable options to enhance 
placental function and nutrient delivery[5]. Adequate placental blood flow is critical to 
ensure proper nutrient delivery between mother and fetus. Additionally, utero-placental 
blood flow is known to increase markedly during the second and third trimesters of 
pregnancy. Thus enhanced placental blood flow could combat the negative consequences 
observed in IUGR pregnancies[6]. Satterfield et al., observed that treatment with 
sildenafil citrate (Viagra) induces vasodilation through inhibition of type 5 
phosphodiesterase (PDE5)[7]. This study included ewes receiving daily subcutaneous 
injections of Viagra from day 28 to 115 gestation in both a nutrient restricted population 
(ewes fed 50% NRC) and adequately fed group (ewes fed 100% NRC). An important 
finding of this study was that ewes receiving Viagra treatment displayed enhanced fetal 
weights at day 115 of gestation by approximately 14% compared to ewes who did not 
receive Viagra treatment regardless of diet.  Additionally, in conjunction with enhanced 
fetal weights increased amino acids and polyamines were also present in the fetal blood 
and placental fluid indicating Viagra treatment has the potential to influence the 
trafficking of nutrients between mother and fetus. Thus these novel findings shed light 
 4 
 
on potential therapeutic means to enhance placental blood flow and thus further define 
and combat the negative consequences of IUGR[5]. Other findings by the laboratory 
have demonstrated that arginine plays a critical role in conceptus development. Arginine 
is metabolized to ornithine, proline, and nitric oxide and can influence pregnancy 
success. Nitric oxide can act as a vasodilator and positively impact angiogenesis while 
ornithine and proline are substrates for synthesis of polyamines [2]. Using our nutrient 
restricted model in which ewes were fed either 100% NRC requirements or were nutrient 
restricted and fed 50% NRC a study was performed to analyze the impact of parenteral 
administration of L-arginine. In nutrient restricted ewes treatment with arginine 
increased concentrations of arginine, ornithine, proline, methionine and numerous other 
critical amino acids. Additionally, ewes treated with arginine exhibited enhanced birth 
weights 21% greater than that of the control. Just as importantly, arginine treated 
nutrient restricted ewes produced lambs with birth weights comparable to the adequately 
fed ewes[8]. Thus these novel findings again lay the foundation for potential theraputic 
means for treatment of IUGR.  
 Interestingly, we repeatedly observed that fetal weights are more variable within 
nutrient restricted ewes than well-fed controls. This observation elucidates the existence 
for a dynamic range of responses to a suboptimal nutritional environment allowing for 
placental adaptations to support normal fetal growth in a subpopulation of nutrient 
restricted ewes. In order to further analyze placental adaptations to maternal nutrient 
restriction and continue to evaluate the consequences of an inadequate gestational 
environment, an additional study was performed to elucidate potential mechanisms 
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regulating fetal nutrient availability and growth. Singleton pregnancies were generated 
by embryo transfer. Pregnant ewes received either 50% NRC (n=24) or 100% NRC 
(n=7) as a control from Day 28 of gestation to necropsy on Day 125. Maternal weight 
did not correlate with fetal weight; therefore the six heaviest (NR non-IUGR) and six 
lightest (NR IUGR) fetuses from nutrient-restricted ewes, as well as the 7 control 
fetuses, were compared to investigate differences in nutrient availability[9]. AGR2 was 
among the novel genes differentially expressed in this studies microarray.  
 The finding of AGR2 in multiple unique studies led us to further question 
AGR2's relevance in ovine pregnancy. Thus the goal of this research is to establish 
localization of AGR2 throughout gestation and lay the foundation for which future 
mechanistic studies to examine function can be designed. As a result the following 
studies are designed to elucidate potential roles of AGR2 throughout the course of ovine 
pregnancy.  
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CHAPTER II
*
 
LITERATURE REVIEW 
 
Conceptus Development and Implantation 
Early Pregnancy Events 
 Establishment and maintenance of a healthy pregnancy that will result in a live 
offspring is the ultimate goal of the reproductive system. Early pregnancy is a critical 
time for embryonic growth and survival. In humans, it is estimated that the likelihood of 
a woman conceiving during one menstrual cycle is 30% and of these pregnancies only 
50% to 60% are likely to survive to 20 weeks gestation [10, 11]. Among these described 
early pregnancy losses, 75% can be attributed to implantation failure [11]. Early 
implantation is not only a critical time in human fertility and reproduction but it is also 
an important window of time in domestic livestock species.  In cattle, greater than 20% 
of reproductive losses occur during the period of maternal recognition of pregnancy 
(approximately Day 15) [12]. In sheep, percentages of embryonic wastage are difficult to 
estimate and likely higher due to multiple ovulations [13]. From a production standpoint 
it is important to understand the mechanisms underlying conceptus development and 
implantation to effectively minimize pregnancy loss and thus positively impact the 
bottom line. In summary, the peri-implantation period is the critical time in which most 
                                                 
*
 Part of the data reported in this chapter is reprinted with permission from "Nutrition and reproduction: 
links to epigenetics and metabolic syndrome in offspring." by DelCurto, H., Wu, G., and Satterfield, M.C. 
2013. Curr Opin Clin Nutr Metab Care, 16(4):385-91. Copyright (2013) by Lippincott Williams and 
Wilkins 
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embryonic deaths occur due to deficiencies in uterine function and failure of the 
conceptus to develop appropriately and initiate pregnancy recognition. Further, 
deficiencies in uterine function and conceptus development that do not directly result in 
early embryonic death may still result in placentation deficiencies resulting in loss of 
advanced pregnancies[14].  Although physiological mechanisms behind placentation and 
implantation are diverse among species, the early steps that occur between the 
trophoblast and maternal uterine endometrial luminal epithelium are similar [15]. Early 
implantation is a highly coordinated process that involves blastocyst hatching, shedding 
of the zona pellucida, apposition, adhesion, and either attachment or endometrial 
invasion depending on the species [16]. Prior to implantation the uterine wall has a 
unique histology. The uterine wall is made up of two components: endometrium and 
myometrium. The myometrium serves as the smooth muscle component of the uterus 
while the endometrium is the sight of the inner mucosal lining of the uterus which will 
eventually make up the maternal component of the placenta [17]. The ovine 
endometrium consists of luminal epithelium (LE), glandular epithelium (GE), the 
stratum compactum and stratum spongiosum of the stroma, blood vessels, and immune 
cells.  Endometrial anatomy and function is conserved among most species. The 
endometrial mucosa is composed of a mono or pseudostratified epithelium which on the 
surface consists of secretory cells containing microvilli and ciliated cells. The mucosa 
and stroma are separated from one another by the basal lamina. The stroma is a highly 
vascularized region that contains coiled and/or branched glands whose ducts will enter 
into the uterine lumen.   In regards to implantation, it is during the blastocyst stage that 
 8 
 
the trophectoderm (Tr) is developmentally competent to attach to the luminal epithelium 
(LE). The LE is of critical importance to establish juxtacrine communication necessary 
to initiate the implantation cascade [15]. Attachment and implantation is a unique 
process, which can be characterized as either non-invasive or invasive depending on 
whether the conceptus invades the uterine LE to imbed into the stroma [18]. In rodents 
and primates the conceptus enters the receptive uterus and almost immediately attaches, 
invades, and expands rapidly; extraembryonic membranes are formed post implantation 
(invasive implantation) [19]. Domestic animals exhibit a noninvasive implantation. Thus 
the conceptus does not invade the stroma. Unique differences can also be witnessed in 
interactions between the maternal and fetal tissues at the maternal-fetal interface. For 
example, in swine, intimate contact between the LE and chorion derived from 
trophectoderm is maintained throughout pregnancy (epitheliochorial placenta). 
Conversely, implantation in ruminants is characterized by the formation of binucleate 
trophectoderm cells that migrate and fuse with the uterine LE to form plaques of 
multinucleated syncytia (synepitheliochorial placenta) [20]. The pregnant sheep is not 
only an ideal model for studying early pregnancy in our economically important 
ruminant livestock species, but is also a model that is used extensively in understanding 
human pregnancy. Researchers have the ability to analyze maternal-fetal interaction in 
the ewe, in part, because of the ability to surgically analyze and maintain catheters in the 
maternal and fetal vasculature [10]. The following is a brief review of the general events 
leading to implantation in the ewe. 
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Pregnancy Recognition 
 The events of implantation can be divided into four basic phases: shedding of the 
zona pelluicida (phase 1), precontact and blastocyst orientation (phase 2) apposition 
(phase 3), and adhesion (phase 4). The morula enters the uterus from the oviduct on day 
4 post mating. The blastocyst is formed on day 6, and the zona pellucida, which is 
thought to prevent the trophoblast from connecting and attaching to the LE is shed on 
day 8 or 9[16]. During this time the blastocyst evolves from a spherical form (200 um) 
on day 9 to an elongated and filamentous "trophoblastic vesicle" form, elongating to 25 
cm or more by day 17 [15, 16]. Following the shedding of the zona pellucida  on day 11 
the blastocyst begins the process of elongation. Elongation of the ovine conceptus is a 
prerequisite for implantation.  At day 12, the blastocyst is approximately 10-22 mm in 
length and at day 14, it has reached 10 cm. Ultimately, the blastocyst will reach length of 
25cm by day 17, and will have taken on a long filamentous form[15]. This elongation 
process is critical for the initiation, synthesis and secretion of interferon tau (IFNT), the 
pregnancy recognition signal of ruminants [21]. Maternal recognition of pregnancy is 
critical for establishment and maintenance of early pregnancy. This communication 
between the signaling conceptus and the maternal reproduction system may be 
established by luteotrophic mechanisms (hormone acts directly on the corpus luteum to 
maintain luteal function) or antiluteolytic mechanisms (the hormone prevents uterine 
release of luteolytic prostaglandin F2α) [18, 22]. Maternal recognition of pregnancy 
results in the maintenance of a functional corpus luteum (CL) that produces progesterone 
and thus is permissive to actions of IFNT, growth factors, and cytokines [18]. Interferon 
 10 
 
tau ultimately silences expression of estrogen receptor α. This effect triggers a cascade 
which prevents estrogen from upregulating oxytocin receptor (OXTR) expression in the 
uterine LE and sGE and thus hinders oxytocin release, ultimately preventing the release 
of pulsatile PGF2α which prevents CL regression [20].  
Apposition 
 The next phase in the implantation process involves apposition in which the 
conceptus becomes closely associated with the endometrial LE. Initial site of apposition 
is at the location of the developing embryo and then is spread across the elongating 
conceptus [16]. At approximately day 14, the embryo becomes immobilized and there is 
close contact between the apical membranes of both maternal and fetal cell types; thus in 
this situation, the trophectoderm is closely pressed against the apical membranes of 
endometrial cells, and these apical membranes actually physically imprint into the apical 
surface of the trophectoderm cell. However, the embryo may still be recovered from the 
uterus intact by lavage at this time [15]. Interestingly, between days 15 and 18, finger 
like projections known as papillae are formed in sheep and cattle (not goat) 
trophectoderm. These structures extend into the superficial ducts of the uterine glands 
and are hypothesized to be necessary for anchoring the conceptus and, by close 
attachment, facilitating the absorption of a rich nutrient supply from histotrophic 
secretion of glands. Histotroph is produced in the superficial GE and mid to deep-gland 
epithelium and includes: nutrient transport proteins, ions, mitogens, cytokines, 
lymphokines, enzymes, hormones, growth factors, proteases and protease inhibitors, 
amino acids, glucose, fructose, vitamins and other substances[23]. Therefore, the uterine 
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glands not only produce histotroph which is essential for conceptus development both 
pre and postimplantation, but also may be critical in anchoring the conceptus against the 
uterine epithelia which allows the initiation of cellular changes during implantation [24, 
25]. 
Adhesion 
 If the preceding phases of pregnancy, described above, are all established and the 
condition of synchrony is met implantation adhesion may begin. At this time, uterine 
microvilli penetrate cytoplasmic projections of trophoblast cells [16]. Adhesion 
progresses along the uterine horn and is generally complete at approximately day 22 of 
pregnancy. This interlocking of microvilli will maintain close attachment of the two 
tissues throughout pregnancy [24]. The engagement of adhesion molecules at the LE and 
Tr surfaces is necessary to transduce cytoplasmic signals essential to maintain both 
maternal and fetal interactions and stimulate the formation of the placenta [26]. One of 
the cellular components necessary for establishment of cell contact is the involvement of 
glycosylated membrane proteins. During the apposition stage the glycocalyx, located on 
the apical membrane surface of trophectoderm cells, increases in thickness. A 
glycoprotein coat is always present at the utero-trophoblast interface throughout 
pregnancy, although it becomes abbreviated during the apposition and adhesion phases 
of implantation[24]. Progesterone is known to play an important role during this time in 
order to establish and maintain pregnancy.  Progesterone receptor protein expression is 
not detectable in the endometrial LE and GE in sheep after days 11 and 13[27]. During 
the implantation period it is common to see a loss in progesterone receptors in 
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mammalian species [28]. It is reasonable to conclude that adhesion and implantation 
may be regulated by the loss of epithelial cell progesterone receptors and specific factors 
implicated in this process[15].   For example, MUC1 is a component of the glycocalyx 
that is abundant on the microvilli extending from the apical cell surface of the 
endometrial LE. MUC1 contains a large amount of glycans and removal of this 
antiadhesive barrier is believed to be necessary for exposure of other glycoproteins 
involved in adhesion. Thus, down regulation of MUC1 is responsible for exposing 
integrin receptors for adhesion molecules and initiating the implantation cascade 
between day 9 and 17 of ovine pregnancy [29]. Additionally, GlyCAM-1, a sulfated 
glycoprotein that mediates leukocyte-endothelial cell adhesion [30] has also been 
identified to show a temporal and spatial pattern in the uterus of cyclic and pregnant 
ewes, thus linking the glycoprotein to be a potential regulator of implantation[15].  
Osteopontin [also known as secreted phosphoprotein 1 (SPP1)], ia a small integrin-
binding ligand, which has numerous physiological roles is also linked to pregnancy[31]. 
In sheep, SPP1 is part of the histotroph secreted from endometrial glands during 
pregnancy [32]. Ultimately, binding of SPP1 to the conceptus trophoblast and uterine LE 
facilitates migration and adhesion of the conceptus as it elongates [31, 32]. Additional 
molecules necessary for implantation include: LGALS15 (lectin, galactoside binding, 
soluble 15) [33]; and IGFBP1 (insulin like growth factor binding protein 1) [34], which 
aid in attachment between the trophectoderm and LE. Early pregnancy events depicted 
in (Figure 2.1). 
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Figure 2.1. Early pregnancy events in sheep. This schematic describes relationships 
between development of the embryo and conceptus with respect to hormonal status and 
position within the maternal uterine environment. Embryos enter the uterus on Days 4-5 
post-fertilization (Day 0), reach the blastocyst stage on Day 6 and hatch from the zona 
pellucida by Day 9. The blastocyst transitions from a spherical to a tubular form by Day 
11. Elongation to a filamentous conceptus occurs between Days 12 and 16 during which 
time the conceptus is apposed to the uterine LE and begins adhesion around Day 16. 
Ultimately, the conceptus will occupy the entire ipsilateral uterine horn and elongate into 
the contralateral uterine horn. The hormone profile of the maternal environment during 
early pregnancy is dominated by progesterone. Copied from (Spencer et al. 2007). 
 
 
Binucleate Cells  
 Binucleate cells play a major role in placental function in ruminants. Formation 
of binucleate cells begins in the trophectoderm as soon as elongation of the conceptus is 
complete [25]. Upon differentiation these binucleate cells lose contact with the basement 
membrane and apical tight junctions allowing them to migrate within the epithelial 
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sheet[35]. Binucleate cells migrate from the trophectoderm into the uterine LE where 
they fuse with individual LE cells to form trinucleate cells which are developed in the 
uterine epithelium on day 16 of pregnancy. In sheep, as opposed to cattle, these 
trinucleate cells are capable of fusions with multiple binucleate cells to produce 
syncytial plaques which ultimately results in a tissue with both fetal and maternal 
components [36]. Continued migration and fusion of the binucleate cells enlarge the 
synctium. Wooding et al., has shown that all binucleate cells migrate and migration is at 
a constant 4-5% of the trophectoderm to form the synctium [37].  Binucleate cells are 
important for the formation of placentomes and also for production of steroid hormones 
and proteins necessary for pregnancy. For the sheep, migration and fusion places the 
syncytial layer opposed to the maternal tissue and thus the binucleate cell granules are 
moved to a position where they can be released by rapid exocytosis into the maternal 
circulation[37].  
The Placenta 
Function and Evolution of the Placenta 
 The placenta is the vital organ in which transport of nutrients, gases, and waste 
products between fetal and maternal circulation occurs [4, 38]. The placenta has two 
evolutionary roles conserved among all species. The first is it generates a large surface 
area for nutrient exchange by the epithelial barrier and fetal blood vessels, all of which 
make up the chorioallantoic placenta. The second basic function is that the trophoblast 
cells interact closely with the uterus which produces histotroph. This interaction allows 
for the production of growth factors, cytokines, and hormones necessary to facilitate 
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blood flow and nutrient delivery to the fetus [39].  Additionally, the placenta also serves 
as a barrier to protect the fetus from the maternal immune system [40].  The first 
recorded scientific description of the placenta was documented by Ionian physician, 
Diogenes of Apollonia, in 480 BC. He was the first person to describe the placenta as an 
organ of fetal nutrition. Others believed that the fetus obtained its nutrients by sucking 
on the uterine lining known as "uterine paps." This theory continued well into the 
Middle Ages. Later, Aristotle dismissed this theory due to the fact that the fetus was 
surrounded by membranes and thus had no direct contact with the uterine lining. Instead 
he drew a correlation to the chick embryo and hypothesized the placenta was like a "yolk 
sac" and provided the nutritional support of the embryo. Galen, a Roman physician, and 
brilliant anatomist, agreed with the ideas of Aristotle, and theorized the embryo was 
nourished by direct connection with the maternal blood via the umbilical cord. Advances 
in science, philosophy, and art, happened rapidly during the Renaissance, and eventually 
gave rise to more detailed understanding and classifications of placental types [41].   
Placental Classifications 
 The earliest most primitive type of chorioallantoic placenta is found in egg-
laying animals in which the chorioallantoic membrane, making up the underlining of the 
eggshell, is necessary for gas exchange and transport of calcium from the shell to the 
fetus [39]. The mammalian placenta is certainly much more complex and takes on a 
variety of other physiological roles such as production of hormones and growth factors, 
vascularization, directing methylation patterns, and regulating expression of specific 
genes, all of which alter maternal physiology and uterine environment [42].  Although 
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the steps of early implantation are conserved among most species, placental structure is 
quite diverse among mammalian species, specifically among the typical research 
models, including: humans, rodents, and ruminants. Mechanisms of placentation are 
characterized by the degree of interaction and number of interposed layers between the 
maternal and fetal circulation as well as according to their distribution of chorionic villi 
[43]. Placental conformation has a wide range of variations. The simplest superficial 
epitheliochorial placenta is displayed in domestic animals in which the uterine LE 
remains intact throughout pregnancy and the embryo is restricted to the uterine lumen. 
Conversely, rodents and humans demonstrate endotheliochorial and hemochorial 
placentas in which the conceptus invades the LE and embeds in the stroma [26]. There 
are several distinct placental types. The diffuse placentas, found in the pigs, have a 
uniform distribution of chorionic villi that cover the surface of the chorion. Rodents and 
primates utilize a discoid placenta which is characterized by having two distinct discs 
that contain chorionic villi that interface with the endometrium for exchange of gas, 
nutrients, and metabolic waste [43].  The sheep (ruminant) has a distinct fetal component 
of the placenta formed from the fusion of the avascular chorion to the vascular allantois. 
Consequently, this placenta type is classified as being primarily cotyledonary [44]. 
The Ovine Placenta 
 Early pregnancy is a critical time for pregnancy survival. Upwards of 30% of 
pregnancy loss can occur in most species at this time, and this total could reach 50% in 
humans [45]. Ruminants have a cotyledonary placenta in which hematotrophic nutrition 
is primarily conveyed from the uterus to the fetus through placentomes, which are 
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structures formed through the interdigitation of fetal cotyledons and maternal caruncles. 
Cotyledons are highly branched villous tree-like folds of fetal chorioallantois which are 
lined by syncytial plaques and protrude into maternal endometrial caruncular crypts 
(aglandular endometrial areas consisting of stroma covered by a single lay of LE. At 
approximately day 17 of gestation attachment is initiated. Chorionic epithelium which is 
overlying the maternal caruncles associates and interdigitates with caruncular tissue. 
Resultantly, by gestational day 40 in sheep there is maximal juxtaposition of endometrial 
and placental microvasculatures [39].  Failure of placentome development results in loss 
of the fetus [46] because these structures provide a source of hematotrophic nutrition 
where maternal and fetal blood vessels are in very close proximity for exchanging 
oxygen and nutrients (Figure 2.2) [47]. 
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Figure 2.2. Schematic Representation of the Sheep Placentome. The maternal 
(caruncular) portion is represented by the strippled areas, and the fetal (cotyledonary) 
area, is represented by the greyish areas. The vascular supply for each portion of the 
placentome is represented by the red (maternal, caruncular) or yellow (fetal, 
cotyledonary) vessels. Figure adapted from Reynolds et al., Journal of Physiology, 2005.  
 
 
 
Angiogenesis in the Placenta 
 The importance of the placenta has been observed and studied since ancient time. 
Multiple factors are necessary for proper placental growth and utilization. Lawrence 
Lingo (1972)  described the placenta saying: 
 
 'The fetal "lifeline" thus includes an adequate maternal placental circulation 
 and supply of blood nutrients, a placenta that transports and metabolizes various 
 substances properly and a functional fetal placental circulation'  
 
 Angiogenesis, the formation of new blood vessels from existing vasculature, is a critical 
factor in placentation [48] which ensures adequate blood flow and thus enhanced fetal 
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growth. Multiple factors can effect angiogenesis and in turn blood flow and fetal nutrient 
delivery such as genotype, number of fetuses, maternal nutrient intake, and 
environmental stress[49]. Vascularization and angiogenesis in the placenta bring about 
morphological changes that alter both number and surface density of capillaries to 
ultimately influence blood flow in the umbilical and uterine circulations [47]. Increased 
placental blood flow is critical to increased transplacental exchange, which is necessary 
for the exponential fetal growth that occurs during the last trimester of pregnancy. 
Ultimately, fetal growth is dependent on the growth of placental and endometrial 
vascular beds, and thus a large increase in uterine and umbilical blood flows [50]. This is 
confirmed in analyzing situations of intrauterine growth restriction (IUGR). It has been 
observed that in human IUGR pregnancies the third trimester is characterized by 
impaired uterine and umbilical blood flows [4]. Reduced blood flow ultimately leads to 
impaired fetal nutrient delivery which has both short term and long term 
consequences[49]. In a normal pregnancy fetal de-oxygenated blood is carried to the 
placenta by the arterial system. This blood will eventually become oxygenated in the 
villous capillary network and then be transported back by the venous system to the fetus. 
Increased uterine blood flow is a primary mechanism for transport of nutrients from 
mother to fetus [44]. 
Utilization of the Sheep Model to Study Placental Angiogenesis      
 The pregnant sheep has been utilized extensively as a model of placental 
angiogenesis and to understand placental blood flow occurring in human pregnancy. 
While a great deal of knowledge has been generated from numerous animal models there 
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have been limitations in the ability to obtain repetitive human samples from both the 
maternal and fetal components of the placenta. This inability limits the usefulness of 
studying placenta and fetal interactions under steady-state conditions [10]. The ruminant 
model rectifies this limitation. The pregnant sheep has specifically been used as a model 
to investigate maternal-fetal interactions, because the sheep possesses the ability to 
surgically place and maintain catheters in both maternal and fetal vasculature[51].  
 With the advantage characterized by the ovine model a great deal of knowledge 
has been generated in regards to placental angiogenesis. Reduced placenta vascular 
development and increased vascular resistance has been linked to early embryonic 
mortality [45]. In modeling of the ovine placenta vascular density has been shown to 
increase continuously throughout gestation. This is different compared to the 
development of the fetal placental cotyledons whose growth remains relatively constant 
until midgestation at which time they then show accelerated growth correlated with rapid 
fetal growth [45].   
Angiogenic Factors 
 Factors shown to be necessary in regulating placental angiogenesis include: 
vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF), and the 
angiopoietin (ANG) protein families [45, 52].  The VEGFs are critical components of 
placental angiogenesis due to their ability to stimulate necessary angiogenic processes 
such as stimulating vascular permeability, as well as vascular endothelial cell protease 
production and migration [53, 54]. VEGFs have been shown to induce angiogenesis in 
both normal conditions as well as pathological processes such as wound healing, 
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coronary ischemia, and tumor growth. To no surprise, VEGF is a critical factor during 
pregnancy. VEGF has been shown to correlate with and play a role in development of 
brain ventricles, kidney glomeruli, and placental tissues during late pregnancy in mice. 
In the sheep, VEGF can be found in placental tissues throughout pregnancy[45].  FGFs 
are unique in that they not only influence placental angiogenesis but also various other 
developmental functions. Specifically FGF have been shown to stimulate differentiation 
of embryonic germ layers [45, 55]. Throughout gestation, FGF is produced in both fetal 
and maternal placental tissue. Additionally, both VEGF and FGF may play a role in 
regulating placental blood flow [45]. For instance, VEGF and FGF have been found as 
contributors in inducing nitric oxide (NO) production. Nitric oxide is a potent 
vasodilator that is necessary in stimulating estrogen-induced increases in uterine blood 
flow[56]. Furthermore, other angiogenic factors are necessary for placental 
development. The ANG family is a necessary regulator of vascular development and can 
have both a stimulatory and inhibitory effect on vascular growth and differentiation[45]. 
The intricate interaction of placental development, blood flow, and environmental 
conditions which influence this interaction are the target of numerous research endeavors 
aimed at improving pregnancy development. Understanding factors that regulate 
placental angiogenesis and in turn overall health of offspring is the first step in finding 
solutions to associated problems. 
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Nutritional Regulation of Reproduction 
Impact of Nutritional Inadequacies  
 Suboptimal nutrition is a far-reaching societal challenge. Whether it is the 925 
million people who are undernourished or the billion adults who are overweight, 
nutritional inadequacies have a significant negative global impact[57]. Importantly, 
many of these nutritionally compromised individuals are reproductively mature adults, 
whereas others are developing children still capable of reproduction in the future. 
Pregnancy is a particularly sensitive period to suboptimal nutrition. From a production 
livestock standpoint nutrition plays a major role in productivity. And in cases of 
suboptimal nutrition the fetus may never be able to reach its genetic potential [58].  
Epidemiological studies have demonstrated links between maternal 
undernutrition/overnutrition and the cause of chronic metabolic disease in adult 
offspring[59]. Metabolic syndrome has been defined as a cluster of disorders, including 
obesity, hyperglycemia [fasting serum glucose (>6.1 mM)], hyperinsulinemia, 
hyperlipidemia, hypertension, and insulin resistance (impaired response of cells or 
tissues to physiological concentrations of insulin)[60]. These epidemiological 
observations have been recapitulated in controlled experimental studies using a variety 
of model systems, and have collectively given rise to the concept of fetal 
programming[4, 61]. Fetal programming proposes that alterations in fetal nutrition and 
endocrine status impacts development; permanently changes structure and metabolism; 
and as a result influences an individual’s susceptibility to disease[62]. These changes are 
mediated at the level of the epigenome, and are observed as stable and sometimes 
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inheritable alterations of genes through covalent modifications of DNA and core 
histones without changes in DNA sequences [63].  
Intrauterine Growth Retardation 
 Maternal nutrient intake and subsequent fetal growth are intricately correlated 
and associated with pregnancy success and overall lifelong health of the offspring [57]. 
A potential hindrance to this interaction occurs in a situation of intrauterine growth 
retardation (IUGR) defined as impaired growth and development of the mammalian 
embryo/fetus or its organs during pregnancy. Multiple factors contribute to an IUGR 
pregnancy. These factors could be naturally occurring restrictions, due to insufficient 
uterine capacity, which pose limitations on conceptus growth and development, as well 
as, dysfunction or insufficiency of the endometrium and/or placenta. Alternatively, 
environmental factors such as nutritional hardships, heat stress, disease, and toxins,  are 
potentially controllable factors that can also contribute to development of an IUGR 
offspring [64-66]. The occurrence of IUGR poses financial strains on both livestock 
enterprises and the human population alike. In humans, IUGR affects 5 to 10% of all 
births. It is estimated that the costs associated with IUGR equate to approximately $2 
billion incurred due to immediate care expenses. Total costs are likely to be much higher 
when the price of lifelong care is taken into account [67]. In livestock enterprises IUGR 
is a significant factor that impacts productivity. One half of all pre weaning lamb deaths 
occur on the day of birth and the largest contributor to perinatal mortality is low birth 
weight. It has been estimated that lambs weighing less than 4 pounds experience a 65% 
mortality rate compared to lambs weighing 9 to 12 pounds at birth that only exhibit a 8% 
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mortality rate[68]. Thus further understanding of the causes of IUGR and subsequently 
methods of prevention is of critical importance in both the human and livestock 
populations. 
IUGR in Livestock 
 From a production livestock context IUGR remains a critical problem due to the 
limited understanding of nutritional regulation of fetal growth[4]. Simplistically, it is 
easy to predict that more offspring lead to more total livestock product, and ultimately 
greater profit for the producer. Certainly, recent advances in the field of reproductive 
technologies, such as embryo transfer, have tested this theory.  One would be quick to 
hypothesize that producing twins in cattle would be an easy way to increase profit; as the 
overhead costs for maintaining a single-calving cow accounts for more than 50% of the 
total costs of production (Guerra-Martinez 1990). Thus, one would assume that by 
doubling the amount of offspring produced by a single cow this would positively impact 
the bottom line. However, this hypothesis does not take into account maternal  
reproductive health and adequate uterine space as well as management of a cow with 
two calves after birth. In cattle, cows that carry twins lose on average 12% body weight 
during the last trimester of gestation and twinning also reduces fetal growth and 
consequent birth weight of offspring. This could lead to decrease weight at sale [4]. 
Thus, careful consideration must be demonstrated in analyzing enhanced production 
technologies. 
 The sheep industry displays a similar situational paradigm. Under ideal 
environmental and management conditions multiple offspring pregnancies increase the 
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prolificacy of the species. However, it is important to note, that increased number of 
fetuses can contribute to placental insufficiencies and thus lower birth weights [69]. In 
fact, in sheep, IUGR can be induced by a multitude of factors. As mentioned, prolificacy 
is an important factor in intensive sheep production however the economic benefits of 
high prolificacy ewes are usually not fully exploited because multi-fetal pregnancies are 
associated with IUGR. Other natural factors can affect birth weight in sheep such as 
maternal age. Lambs born to relatively young ewes and relatively old ewes generally 
possess lower birth weights [70]. Seasonality can also be an indicator of birth weight. 
Lambs born in the fall and summer are generally lighter than those born in the spring 
and winter; which can possibly be explained by alterations in melatonin and seasonal 
effects on gestation. Additionally, gestation occurring in the warmer months where ewes 
shuttle blood flow to the periphery of the body to dissipate heat rather than to the core 
could  ultimately decrease placental blood flow and placental growth[71]. Finally, 
altitude is another factor that affects lamb birth weights. Lambs that are born at high 
altitude may experience hypobaric hypoxia and be lighter than lambs born at a lower 
altitude. All of these situations can ultimately lead to IUGR offspring who possess 
reduced survival ability (Figure 2.3) [70].  
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Figure 2.3. Birth weights and perinatal survival rates for lambs. Lambs (n=4 781) born 
to Afec-Assaf ewes (Volcanic Center, Israel) according to litter size (after Gootwine and 
Rozov (2006)). Copied from (Gootwine et al., 2007) 
   
 
 Maternal nutrition is arguably the most important and potentially manageable 
factor that contributes to pregnancy and maternal health [72]. Various livestock species 
are produced in different environmental conditions. Swine are commonly produced in a 
confinement setting and are fed specifically formulated plant based diets (intensive 
systems). On the other hand ruminants, such as cattle and sheep, are more commonly 
managed under grazing systems. However, the quality of the grazing system is directly 
dependent on availability of nutrients, which is usually limited during the winter months 
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and times of dry conditions. Thus nutrient availability may be limited for adequate 
growth and development as well as proper gestation and lactation [73] [4]. The sheep, in 
particular, is a seasonal breeder which enters estrus in fall and early winter. Therefore, 
most of gestation occurs in the winter months, a time of low forage quality and limited 
nutrient availability [74]. In fact, Thomas and Knott reported, that without 
supplementation, the nutrient consumption of grazing ewes in the Western United States 
is often less than 50% of the National Research Council (NRC) recommendations [75]. 
 Researchers and care providers alike try to find efficient and non invasive means 
for preventing the continuous occurrence of IUGR and premature delivery. Thus using 
nutritional means are an attractive option for non-invasive prevention. In order to fully 
utilize nutritional intervention one must understand the mechanisms by which nutrition 
mediates fetal growth. Using humans as research models is an unethical option, thereby 
the sheep is an attractive alternative. The sheep has a relatively long gestational period 
compared to other laboratory models (approximately 147 days), a single pregnancy can 
be sustained in a sheep, and there are many similarities to humans with respect to fetal 
size, organ development, and physiology and maturity at birth [76]. To begin, nutritional 
status and maternal weight/ adiposity have been shown to be an indicator of successful 
pregnancy in the sheep model.  Ewes that were lighter and thinner at mating, and thus 
exhibited low nutrient intake, had lambs with an associated 13% decreased birth weight 
[77]. Ultimately, the hypothesis is that these alterations in fetal growth may be mediated 
by a hindrance of the placental growth trajectory [77]. While limited studies have been 
conducted to correlate these findings in women; a study conducted in Chinese women 
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found that being severely underweight at conception equated to a significant decrease in 
birth weight and an 80% higher risk of IUGR [78]. A great deal of research has also 
been conducted in the ewe with respect to the interaction with nutritional and placental 
development and morphology. Recognizing that placental development is a major 
indicator of birth weight, researchers have found an ever occurring commonality among 
studies. The morphology of the placenta is altered under nutrient scarce conditions, with 
the most notable change being increased development of the fetal cotyledon. This 
change is thought to reflect an adaptive compensatory response to maximize 
transplacental exchange and thus fetal growth[76, 79, 80]. 
Maternal Undernutrition and Metabolic Syndrome 
The impact of intrauterine growth retardation is not only substantial in domestic 
livestock but is also a global problem in the human population. There are approximately 
350,000 low birth weight infants born each year in the United States. On average each 
one of these infants required immediate medical care at a cost of $57,000 per infant[67], 
which equates to a total of nearly $2 billion per year. This factor does not take into 
account the long-term costs of continuous health care and special education that may be 
required as the low birth weight infants that survive the neonatal period have an 
increased risk for lifelong complications including neurological and developmental 
disabilities. Ultimately, the long-term costs of premature and growth restricted infants is 
estimated to be $363,000 per surviving baby[81]. The economic impact also does not 
take into account the psychological stress more likely to be experienced by mothers of 
low birth weight offspring [82]. The impact of maternal nutrient deprivation and the 
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resultant long-term consequences to health of the human offspring have been extensively 
studied since the seminal findings by Barker et al. related to the Dutch Famine [83]. 
Intensive study of The Dutch Famine (1944-1945) found that not only does gestational 
undernutrition have critical effects on adult health but also the timing of exposure in 
relation to stage of pregnancy determines severity of effects in addition to the organs that 
are compromised. Organs affected are based on tissue development taking place during 
that specific time of gestation [84]. In regards to growth, women exposed to famine 
during the second or third trimester had offspring with reduced weight, length, and head 
circumference [85]. Currently, much of the work has now shifted to understanding the 
epigenetic mechanisms by which the fetus programs critical metabolic set points in 
response to maternal dietary cues. It should be noted that inadequate nutrition during 
pregnancy not only occurs due to a lack of food, but may also result from severe nausea 
and vomiting, known as hyperemesis gravidarium early or closely spaced pregnancies, 
and multifetal pregnancies, commonly associated with assisted reproductive 
technologies [57]. Luther et al., specifically addressed fetal programming concerns 
associated with adolescent pregnancies. Adolescents who become pregnant have a 
greater risk of premature delivery, low birth weight, neonatal mortality, and maternal 
death, due in part, to poor nutrient stores [86]. Furthermore, propensity to adult disease 
is not always predicted by growth rate in utero, assessed using standard gross measures. 
Birth weight is a valuable tool for clinicians to assess the level of nutrition available to 
the fetus during pregnancy. Primary growth of the fetus occurs in the third trimester, 
thus growth effects due to nutrient restriction are more visible at this time [4]. However, 
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this does not mean that maternal undernutrition only has a major impact during the third 
trimester of pregnancy. In fact, the effect of gestational undernutrition critically depends 
on the stage of pregnancy, with early gestation being a critical time for developing 
metabolism and overall offspring health [83]. Thus, long-term health consequences can 
occur in the absence of changes in birth weight [83]. 
But maternal nutrient restriction does not only have negative consequences. In 
this discussion, it is important to take into account that restricted fetal growth could be 
an adaptation to a problematic uterine environment that allows the fetus a greater chance 
of survival [87]. This adaptation, however, could involve the partitioning of nutrients to 
organs critical for survival such as the brain and heart, while other organs less critical to 
survival (pancreas and kidney) are nutritionally compromised [88]. This situation gives 
rise to what is termed the “thrifty phenotype,” which proposes that there is an association 
between poor nutrition in early life and permanent changes in glucose and insulin 
metabolism [89] Early postnatal nutrition also may affect the function and development 
of the gut microbiota, and having deficient digestive microbiota in early life could 
contribute to problems with immunity and overall health later in life [90]. 
A growing body of experimental evidence from animal models has given rise to 
relevant and interesting findings in regard to the effect of global or specific maternal 
nutrient restriction on the development of adult metabolic disease. For example, global 
nutrient restriction has been shown to increase the risk for obesity, cardiovascular 
disease, and type 2 diabetes in a variety of animal models [4, 91]. Similarly, maternal 
protein restriction results in hypertension and vascular dysfunction in offspring in a sex-
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specific manner [92, 93]. Interestingly, high cholesterol in offspring from rats exposed to 
a protein-restricted diet coincided with repressive histone modifications at the 
cholesterol 7 alpha hydroxylase promoter[94]. In sheep, feeding a diet deficient in 
specific B vitamins and methionine during the periconceptional period of pregnancy may 
resulted in hypertension and adiposity, predominantly observed in male offspring[95]. 
This was associated with global changes in methylation status in the liver of these 
offspring. 
Importance of Gestational and Early Life Nutrition 
 The challenges associated with pregnancy undernutrition are evident. Not only 
can this nutritional status pose health problems in mature adults, but just as concerning, 
these problems may manifest themselves in the offspring of obese or undernourished 
individuals. Multiple factors can affect epigenetics and gene expression, which can 
ultimately program development and long-term health of offspring[4, 57]. Therefore, 
gestational and early life nutrition are critical to determine long-term developmental fate. 
Using a model of maternal nutrient restriction in the ewe we have observed numerous 
developmental and physiological differences between adequately fed and nutrient 
restricted mothers. Among our unique observations, AGR2 arose as a novel gene that 
was identified in this research model. Throughout pregnancy AGR2 is expressed in the 
uterus and is present in the placentome. The goal of this research is to determine AGR2's 
potential roles throughout pregnancy in conditions of differential nutrient intake and 
ultimately determine effective means of addressing the concerns associated with 
unbalanced early life nutrition. 
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Anterior Gradient Homolog 2 
Introduction to AGR2 
 Anterior gradient homolog 2 (AGR2) has a wide range of evolutionarily 
conserved roles. AGR2 protein expression is known to induce metastasis, act as a p53 
tumor suppressor inhibitor and survival factor, and participate in neoplastic 
transformation [96]. Currently, there is intensive research being conducted on AGR2 and 
its role in cancer and tumor development. When AGR2 is downregulated in humans it 
serves as a candidate for inflammatory bowel disease; and decreased AGR2 mRNA 
equates to increased risk of Chrohn’s disease. Conversely, when AGR2 is upregulated it 
contributes to neoplasm development and elevated AGR2 levels have been described in 
various tumor tissues. This includes non hormonal type tumors such as those found in 
the esophagus, gastrointestinal tract, and lungs; as well as hormonal tumors such as 
breast, prostate, and ovarian tumors [96-98]. These hormonal tumors provide a direct 
correlation to hormonal changes during pregnancy. Multiple highly conserved genes 
important in early embryonic development, such as those belonging to the Wnt and 
Hedgehog pathways, have been found to significantly influence tumor development 
[99]. AGR2 may also be involved in such developmental gene pathways and thus could 
play a significant role in pregnancy. However, the roles of AGR2 in pregnancy have not 
been evaluated. The purpose of this review is to shed light on the known function and 
characteristics of AGR2 and thus possibly elute its potential physiological roles during 
pregnancy. 
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Characterization of the Anterior Gradient Gene Family  
 Anterior gradient (AGR) genes were first described in Xenopus laevis (XAG) 
where their expression is responsible for the development of the cement gland [96, 100]. 
Agrs encode for proteins belonging to the protein disulphide isomerase family (PDI), 
which accelerate the folding of other proteins by means of disulphide bond formation. 
The Agr family of genes are intriguing due to their ability to be secreted from the cell 
and their subsequent role in cell growth and differentiation, specifically in embryonic 
and tumor development [101]. By dissection of X. laevis embryos, XAG-1, XAG-2, and 
XAG-3 each were identified to be first expressed in the dorsal ectoderm of late gastrula 
embryos.  Specifically, studies show that XAG-2 works to determine the fate of the 
dorso-anterior ectoderm and forms the cement gland. The cement gland forms columnar 
epithelium which serves as the area of attachment of the frog embryo to solid 
support[102]. Interestingly, the newt AG homolog (nAG) was the first protein 
discovered that could promote limb regeneration [96]. AGR1, also named ERP18/19, 
could be considered the founding member of the AGR family. Its function involves its 
ability to form mixed disulphides with proteins in the endoplasmic reticulum however 
there is still little known about this specific AGR.[103]. AGR1 is found within complex 
invertebrates[97]. AGR2 and AGR3 seem to have emerged in chordates and thus far 
their expression is confined to vertebrates. Most research has been done on validating 
the AGR2 protein, the homologus AGR1 and AGR3 have also been identified [97]. 
AGR3 shares 71% sequence similarity with AGR2. AGR3 was initially identified in 
estrogen receptor positive breast tumors and is upregulated in some ovarian cancers 
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[104]. Still, many tumors that express AGR3 can be AGR2 negative suggesting their 
expression is not necessarily coupled [97]. Additional studies are needed to further 
identify the role of the AGR family in biology. 
AGR2 Interaction with Amphiregulin 
 Although mainly localized in the ER, AGR2 has the ability to play other 
intracellular roles, such as to induce epidermal growth factor (EGF) receptor ligand 
amphiregulin (AREG)[105] and interact with the AAA+ protein Reptin [100]. Thus, 
several studies have revealed that AGR2 supports many of the transformed properties of 
adenocarcinoma cell lines through potential activation of the Hippo signaling pathway 
and induced expression of AREG[105-107]. Work by Dong et al., found that AGR2 and 
AREG are co-expressed in human adenocarcinoma cells. AREG is an EGFR ligand that 
is expressed in higher vertebrates [105].  Specifically, AREG has been identified in the 
sheep mammary gland suggesting a role for amphiregulin in normal mammary 
development [108]. Dong et al., discovered that AGR2 expression stimulates AREG and 
the EGFR signaling pathway which is responsible for increased cell proliferation and 
anchorage-independent growth. Additionally, the Hippo pathway, which serves to 
regulate cell proliferation, apoptosis and functions to regulate organ size, is another 
potential AGR2 induced pathway. Yes-associated protein (YAP1) is a coactivator of 
transcription in the Hippo pathway and is responsible for AREG expression in breast 
epithelial cell lines[109]. Dong et al., showed that AGR2 induces AREG expression 
through YAP1 dephosphorylation [105]. 
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AGR2 Interaction with Reptin 
 Recently, a protein named Reptin was identified as an AGR2 binding protein in a 
yeast two-hybrid screen and validated as an interacting protein with AGR2 in human 
cells [110]. Reptin belongs to a family of proteins known as AAA+ ATPases (ATPases 
associated with various cellular activity) [111]. Discovered by several laboratories in the 
late 1990's, Reptin is also known as Ruvbl12 or Tip48 [112]. Reptin is a necessary 
protein in various cellular functions. The protein Reptin is critical in assembly of protein 
complexes that play a role in regulation of cellular energetic metabolism, transcription, 
chromatin remodeling, DNA damage response, and nonsense mediated RNA decay 
[113]. Of noteworthiness, Reptin expression and regulation appears to follow a sexual 
dimorphism, specifically in the liver, as Reptin mRNA levels have been revealed to be 
four fold higher in male mouse livers versus expression in the female liver [114]. Reptin 
has been shown to be overexpressed in liver tumors and a high Reptin level is correlated 
with a poor prognosis [115]. Although findings of Reptin in other cancerous tumors are 
limited, Reptin, like AGR2, has been specifically identified in breast cancer.  As 
previously mentioned, Reptin interacts with AGR2 by specific binding and the ATP 
binding domains and thus conformation of Reptin play a role in driving the stability of 
the AGR-Reptin complex [110]. Specifically, AGR2 uses a divergent-binding loop to 
bind to Reptin, and then Reptin uses two allosterically interacting ATP binding motifs to 
control its binding activity toward AGR2. Because both proteins are identified in cancer, 
AGR2 and Reptin are both thought of as potential anticancer therapeutic targets. By 
using biochemically based screening assays and by analyzing the substrate binding loops 
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of AGR2 or ATP binding motifs of Reptin there is a potential for scientific 
advancements that could allow for the development of small molecules that regulate the 
AGR2-Reptin binding complex [110]. Further research is sure to be conducted to 
determine greater detail and specificity of the Reptin- AGR2 interaction. 
AGR2 Interaction with Caudal Type Homeobox 2 
  Additional studies have also linked AGR2 with the expression of the 
transcription factor caudal related homeobox 2 (CDX2). Dong et al., screened for 
markers of intestinal development and found that expression of CDX2 was induced upon 
expression of wild-type AGR2 in IEC-6 (a rat small intestinal jejunum cell line) cells 
[105]. The induction of CDX2 expression by AGR2 stimulation is interesting in a 
reproductive context because CDX2 regulates trophectoderm differentiation as well as 
the trophoblast specific gene, interferon tau (IFNT), in ruminants  [116].  Interferon Tau 
(IFNT) is the pregnancy recognition signal in all ruminants [20]. Although a great deal is 
known about IFNT, its transcriptional mechanisms have not been fully characterized. In 
recent years great progress has been made in detecting uterine-derived factors and key 
placental specific transcriptional regulators which makes IFNT an interesting molecule 
in determining maternal-fetal interactions during early pregnancy[117, 118].  In regards 
to CDX2, a great deal is known about its role in embryonic development. CDX2 is 
isolated to the trophectoderm and is essential for ensuring correct segregation of the 
inner cell mass and trophectoderm cell lineages in blastocysts, as CDX2 ensures the 
repression of Oct4 and Nanog in the trophectoderm [119]. Interestingly, Tead4 (a 
transcription factor necessary for trophectoderm formation) along with its coactivator 
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protein Yap, can induce and lead to changes in expression of CDX2[120]. This finding 
correlates to the interaction of AGR2 with its downstream target AREG. Both AREG 
and CDX2 are downstream targets of YAP activation and both are involved in the Hippo 
signaling pathway (Figure 2.4).  
 
 
 
 
Figure 2.4. AGR2 biological pathways. AGR2 is presented as the central point of this 
picture. Pathway intermediates known to regulate AGR2 expression are indicated in 
light grey ovals. AGR2-dependent functions are indicated in dark grey ovals. Potential 
(not experimentally demonstrated) intermediates are indicated as empty ovals. 
Physiological/pathophysiological inputs or outputs are represented by grey boxes. 
Adapted from Chevet et al., 2013. 
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AGR2's Role in Cancer 
 AGR2 has garnered major scientific attention recently due to its potential role in 
tumor development and cancers. Numerous reports have analyzed hormone dependent 
cancers such as breast, prostate, and ovarian cancer, as well as non-hormonal types such 
as esophagus, gastrointestinal tract and lung cancer [96]. Recent cell culture experiments 
have demonstrated that when cultured under serum depleted conditions and/or hypoxia, 
AGR2 was activated to promote angiogenesis, motility and invasion. Therefore, these 
findings demonstrate evidence that AGR2 contributes to the survival of cells undergoing 
physiological stress [121]. In a reproductive context, AGR2 has been associated with 
breast cancer. In breast cancer cell lines AGR2 has been linked with estrogen receptor 
alpha (ERα). In fact, estrogen has been shown to cause AGR2 to become 
transcriptionally activated by direct binding of the ER [122]. AGR2 knockout mouse 
models indicate that in the mammary gland the gene promotes lobuloalveolar 
development by stimulating cell proliferation[98, 123]. When AGR2 is secreted it has 
been found to play a role in cell adhesion and facilitating communication pathways 
elicited by a metastatic tumor[123]. Tamoxifen is an antagonist to the estrogen receptor 
in breast tissues; however in other tissues, such as the endometrium, it can be viewed as 
an agonist. Tamoxifen is used as a primary therapy in treating estrogen hormone 
receptor-positive breast cancers serving as an anti-estrogen therapy[124].  While 
Tamoxifen is a proven cancer therapy intrinsic and acquired resistance can be a problem. 
AGR2 is an identified gene that might mediate the resistance of breast cancer to 
Tamoxifen [96, 97]. Although AGR2 has been strongly correlated with estrogen in 
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breast cancer cells other regulatory factors are likely to exist. This is demonstrated by 
Innes et al., finding inconsistency of AGR2 expression in breast cancer scenarios [125]. 
Poor prognosis is indicated by AGR2 expression in estrogen-positive breast cancers.  
However, AGR2 was present in one third of ER-negative cases and was not consistently 
expressed in ER-positive breast cancers;  suggesting the mechanism(s) by which AGR2 
is regulated in these cancer cell lines remain to be fully understood [125].  In regards to 
prostate cancer, both estrogens and androgens stimulate AGR2 expression [104]. AGR2 
mRNA is present in normal prostate tissue. However, AGR2 expression markedly 
increases in cancerous conditions of the prostate. Although the fact that AGR2 is present 
in not only normal prostate tissue, but also normal colon, pancreatic, and lung tissue, 
limit its use in cancer treatment, progress has been made in identifying AGR2's role in 
prostate cancer [96]. Two forkhead transcriptional factors, Foxa1 and Foxa2 positively 
regulate the AGR2 promoter in prostate cancer. Additionally, ErbB3 binding protein 1 
(EBP1) has been found to suppress the invasive ability of cells by inhibiting AGR2 
expression. This binding protein has been implicated as a negative regulator of androgen 
receptor signaling[126]. Immunohistochemical analysis has also demonstrated that 
AGR2 expression is restricted to secretory epithelial cells of the prostate gland [127]. 
Recent findings using immunohistochemical staining of ovarian tissues have 
demonstrated that AGR2 protein was expressed at a basal level in normal ovary surface 
epithelium[128]. Conversely, cancerous tissues present moderate to strong staining of 
AGR2. Park et al., demonstrated that AGR2 enhanced cell growth and migration of 
ovarian cancerous cells. AGR2 can also be detected in the serum of mucinous ovarian 
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tumor patients, which suggests AGR2 could be a potential biomarker for patients with 
ovarian cancer [128]. The primary research focus revolves around AGR2's role in 
cancer, and thus certainly, comparisons can be drawn between cancer and embryonic 
development. It is currently hypothesized that in order for a new tumor to develop, the 
cancer cell is likely to resurrect early embryonic behavioral programs. Movement and 
development of the embryo can be likened to metastasis [129]. In new tumor 
development cells acquire both genetic and epigenetic changes that allow them to 
proliferate and to stimulate angiogenesis[130].  Cancer cells can thus take on a 
phenotype similar to that of early embryonic cells and express unique embryonic 
transcription factors. These transcription factors have the ability to allow cancer cells to 
move, become invasive and resist programmed cell death comparable to what is 
witnessed in the early stages of pregnancy[129]. Thus this correlation provides an 
intriguing idea to base future research pursuits. 
 
 
 41 
 
CHAPTER III  
ANTERIOR GRADIENT HOMOLOG 2 AND ITS POTENTIAL ROLES IN 
OVINE PREGNANCY 
 
Introduction 
 Anterior gradient homolog 2 (AGR2) has a wide range of evolutionarily 
conserved roles. AGR2 protein expression is known to induce metastasis, acts as a p53 
tumor suppressor inhibitor and survival factor, and participates in neoplastic 
transformation[96]. Currently, there is intensive research being conducted in regards to 
AGR2's role in cancer and tumor development. When AGR2 is downregulated it is an 
autoimmune regulator of inflammatory disease. In humans it serves as a candidate for 
inflammatory bowel disease; and decreased AGR2 mRNA correlates to increased risk of 
Chrohn’s disease. Conversely, when AGR2 is upregulated it contributes to neoplasm 
development, and elevated AGR2 levels have been described in various tumor tissues. 
This includes non hormonal dependent tumors such as those found in the esophagus, 
gastrointestinal tract, and lungs; as well as hormonal dependent tumors such as breast, 
prostate, and ovarian tumors [96-98]. These hormonal tumors provide a correlative link 
to hormonal changes during pregnancy. Multiple highly conserved genes important in 
early embryonic development, such as those belonging to the Wnt and Hedgehog 
pathways, have been found to significantly influence tumor development [99]. AGR2 
may be involved in such developmental gene pathways and thus could play a significant 
role in pregnancy. However, the roles of AGR2 in pregnancy have not been evaluated. 
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Our laboratory has demonstrated that AGR2 expression in the ovine endometrium 
increased between days 9 and 12 post mating, and was stimulated by progesterone. 
Additionally, using a model of maternal nutrient restriction AGR2 was found to be a 
gene present in the placentome during late gestation. These findings led to further 
evaluation of AGR2 and its characterization throughout ovine pregnancy. 
Materials and Methods 
Animals 
  Mature Suffolk ewes (Ovis aries) were observed daily for estrus in the presence 
of vasectomized rams and used in experiments only after they exhibited at least two 
estrous cycles of normal duration (16–18 days). All experimental and surgical 
procedures were in compliance with the Guide for the Care and Use of Agriculture 
Animals and approved by the Institutional Animal Care and Use Committee of Texas 
A&M University and Washington State University (Study 2). 
Experimental Designs 
 Study 1:  At estrus (day 0), ewes were mated to either an intact or vasectomized 
ram as described previously [131] and then hysterectomized (n = 5 ewes/d) on day 10, 
12, 14, or 16 of the estrous cycle or day 10, 12, 14, 16, 18, or 20 of pregnancy. 
Pregnancy was confirmed on day 10–16 after mating by the presence of a 
morphologically normal conceptus(es) in the uterus. At hysterectomy, several sections 
(∼0.5 cm) from the midportion of each uterine horn ipsilateral to the corpus luteum were 
fixed in fresh 4% paraformaldehyde in PBS (pH 7.2). After 24 h, fixed tissues were 
changed to 70% ethanol for 24 h and then dehydrated and embedded in Paraplast-Plus 
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(Oxford Labware, St. Louis, MO). The remaining endometrium was physically dissected 
from myometrium, frozen in liquid nitrogen, and stored at −80 C for subsequent RNA or 
protein extraction. In monovulatory pregnant (PX) ewes, uterine tissue samples were 
marked as either contralateral or ipsilateral to the ovary bearing the corpus luteum. No 
tissues from the contralateral uterine horn were used for study. Uterine flushes were 
clarified by centrifugation (3000 × g for 30 min at 4 C) and frozen at −80 C for Western 
blot analysis. 
 Study 2: Ewes (n= 40) were detected for estrus using a vasectomized ram. Using 
a surgical approach described previously [132, 133], ewes on day 10 after estrus were 
subjected to a midventral laparotomy, and the lumen of each uterine horn received a 
vinyl catheter (0007760; Durect Corp, Cupertino, California) connected to an Alzet 
2ML1 osmotic pump (Durect Corp) secured within the infundibulum of the oviduct and 
mesovarium. Ewes (n=5 per treatment) received pumps containing the following: 1) 2 
mL of vehicle as a control [CX; 2% ethanol (vol/vol) in saline]; 2) 156 ng cortisol 
(CORT) in 2 mL of vehicle; 3) The amount of cortisol pumped into the uterine lumen on 
a daily basis (23 ng) mimics cortisol production by an elongating day 14 ovine 
conceptus [133]. Recombinant ovine IFNT was prepared as described previously [134], 
and the amount of recombinant IFNT pumped into the uterine lumen on a daily basis 
(14.4 µg) mimics IFNT production by an elongating day 14 ovine conceptus, which is 
600 ng/h [135]. Our previous studies found that infusion of that amount of IFNT in the 
uterine lumen each day mimics effects of the conceptus on endometrial expression of 
hormone receptors and IFNT-stimulated genes during early pregnancy in ewes [132, 
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136]. At necropsy on day 14 after estrus, the female reproductive tract was excised and 
endometrium was physically dissected from myometrium, frozen in liquid nitrogen, and 
stored at -80°C for subsequent RNA extraction. All experimental procedures were in 
compliance with the Guide for the Care and Use of Agriculture Animals in Research and 
Teaching and approved by the Institutional Animal Care and Use Committee at 
Washington State University. 
 Study 3: At estrus (day 0), ewes were mated to an intact ram and then 
hysterectomized (n = 5 ewes/day) on either Day 40, 60, 80, 100, or 120 of pregnancy 
(gestation period is 147 days). At hysterectomy, the uterus was trimmed free of cervix 
and oviduct and opened along the mesometrial border. Several sections (∼0.5 cm) of 
interplacentomal and placentomal areas of uteroplacental tissues were fixed in fresh 4% 
paraformaldehyde in PBS (pH 7.2). Placentomes were then removed by physical 
dissection, and intercaruncular endometrium was dissected from the myometrium. 
Samples of intercaruncular endometrium and placentomes were frozen in liquid nitrogen 
and stored at −80 °C for RNA extraction. 
 Study 4: Mature Suffolk ewes of similar parity and frame size were fed 100% of  
NRC requirements to maintain their body condition prior to embryo transfers.  Ewes 
were synchronized into estrus and a single embryo from a superovulated donor ewe of 
normal body condition was transferred into the recipient uterus on post-estrus Day 6.  
Pregnancy was determined by ultrasonography on Day 28.  On Day 35 of gestation, 
ewes were randomly assigned to receive either 50% of their daily nutrient requirements 
(n=24) or 100% of their daily nutrient requirements as control (n=7), based on the 
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National Research Council guidelines.  The ewes were kept in separate pens and 
individually fed once daily from Day 35 to 125.  Weights were collected weekly 
beginning on Day 28 to adjust feed intake with weight gain or loss.  On Day 125 of 
gestation (term = 147) ewes were necropsied and conceptus (fetal-placental unit) 
development was measured. Following euthanization, the fetus was removed, weighed, 
measured, and dissected. A portion of the uteroplacental-unit was removed and 
placentomes were dissected, counted, and weighed.  Placentomes were then either snap 
frozen in liquid nitrogen and stored at -80⁰C or preserved in 4% paraformaldehyde.  
(Figure 3.1) 
 Study 5: Mature Suffolk ewes of similar parity and frame size were fed 100% of 
their NRC requirements to maintain their body condition prior to embryo transfers.  
Ewes were synchronized into estrus and a single embryo from a superovulated donor 
ewe of normal body condition was transferred into the recipient uterus on post-estrus 
Day 6.  Pregnancy was determined by ultrasonography on Day 28.  On Day 35 of 
gestation, ewes were randomly assigned to receive either 50% of their daily nutrient 
requirements (n=32) or 100% of their daily nutrients requirements as control (n=32), 
based on the National Research Council requirements.  Ewes were randomly assigned to 
necropsy on Day 50, 75, 100, 125, or term (Day 147), (n=4-7 per day and diet) and 
conceptus (fetal-placental unit) development was measured.  Ewes were maintained and 
cared for at the Texas A&M Nutrition and Physiology Center.   
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Figure 3.1. Experimental model. Singleton pregnancies were generated in mature 
Suffolk ewes of similar weight and body composition (n=31) via embryo transfer.  
Embryos were collected from superovulated Suffolk ewes mated to genetically similar 
sires.  Pregnant ewes were individually housed from Day 28 to 125 of gestation.  
Beginning on Day 35 and continuing to necropsy, ewes were fed 50% (n=24) or 100% 
(n=7) of NRC requirements.  Ewes fed 100% NRC are identified as control.  
 
 
RNA Extraction and Affymetrix GeneChip Array Analysis 
 As previously conducted by Spencer et al., total RNA was extracted from 
approximately 100 mg of placentome using TRIzol reagent as per manufacturer’s 
instructions (Invitrogen) and by column DNAse treatment, and clean-up was performed 
(Qiagen)[137].  Both quality and quantity of RNA were determined using the Agilent 
Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA) and the NanoDrop 1000 
(Thermo Fisher Scientific, Inc., Wilmington, DE, USA) respectively.  Only samples with 
an RNA integrity number > 8.0 were used for microarray analysis.  A Gene Chip One-
cycle Target Labeling Kit (Affymetrix, Santa Clara, CA, USA) was used to label total 
RNA, which was then hybridized to the Affymetrix GeneChip Bovine and Ovine 
Genome 1.0 ST Arrays.  Hybridization quality was assessed using GCOS 1.4.  
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Hybridization probes for the Affymetrix GeneChip Bovine and Ovine Genome 1.0 ST 
Arrays were prepared using 10 mg of total RNA and the One-Cycle Target Labeling and 
Control Reagent package.  The GeneChip Hybridization, Wash, and Stain Kit and a 
Fluidic Station 450 were used for the hybridization, wash, and staining process.  All 
steps were carried out according to the manufacturer’s protocol.  The processed arrays 
were scanned with a GeneChip Scanner 3000. 
Array output was normalized via the robust multiarray method, and probe sets 
were filtered based on expression calls, as previously described [137, 138]. Data analysis 
was conducted using the GeneSpring GX Software (Agilent Technologies) using 
ANOVA (PZ0.05) with a Benjamini and Hochberg false discovery rate multiple test 
correction to determine differentially expressed genes.  
Database for Annotation, Visualization, and Integrated Discovery 
 DAVID version 6.7 (http://david.abcc.ncifcrf.gov/home.jsp) facilitates the use of 
microarray gene lists to generate specific functional annotations of biological processes 
affected by treatment in microarray experiments [139-141].  DAVID was utilized, as 
previously described, to annotate biological themes in response to dietary treatment 
[141]. All differentially expressed genes identified to be both significantly (P ≤ 0.05) and 
numerically (1.5-fold change or greater) different and homologous to a known and 
annotated human gene were used in the DAVID analysis. The background list utilized in 
the program included all genes assigned a human accession number that were present on 
the bovine or ovine oligo array. With Gene Ontology (GO) terms as identified through 
biological mechanism, cellular component, and molecular function, along with protein 
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domain and biochemical pathway membership, DAVID generated biological themes by 
grouping similar terms, ultimately creating functional annotation clusters associated with 
effects of dietary treatment [141]. 
RNA Isolation and Real-Time PCR 
 Total cellular RNA was isolated from frozen placentome using Trizol reagent 
(Gibco-BRL) according to the manufacturer's instructions. The quantity and quality of 
total RNA was determined by spectrometry and denaturing agarose gel electrophoresis, 
respectively. Total RNA from each sample was reverse transcribed in a total reaction 
volume of 20 μl. Briefly, total RNA (4 μg) was combined with primer mix containing 
oligo (dT) primer (0.2 μg/ml), random hexamer primer (300 μg/ml) (Invitrogen), and 
dNTP mix (10 mM each), and incubated at 65°C for 5 min. A reverse transcriptase mix 
containing 5× first-strand buffer, 100 mM DTT (dithiothreitol) and SuperScript II 
reverse transcriptase (Invitrogen) was added to the reaction, and reverse transcription 
was performed under the following conditions: 25°C for 10 min, 42°C for 60 min, and 
70°C for 5 min. Control reactions in the absence of reverse transcriptase were prepared 
for each sample to test for contamination with genomic DNA. The resulting cDNA was 
stored at −20°C for further analysis. 
 Real-time PCR was performed using ABI prism 7900HT system (Applied 
Biosystems) with Power SYBR Green PCR Master Mix (Applied Biosystems). Specific 
oligonucleotide primers were designed by Oligo 5 program (Molecular Biology Insights, 
Inc.) (see Supplemental Table 3.1). Primer specificity and efficiency (−3.4 > slope > 
−3.2) were confirmed using a test amplification run. Each individual sample was run in 
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triplicate under the following conditions: 50°C for 2 min; 95°C for 10 min; 95°C for 15 
sec and 60°C for 1 min for 40 cycles. A dissociation curve was generated at the end of 
the amplification to ensure that a single product was amplified. PCR without template or 
template substituted with total RNA was used as a negative control to verify the 
experimental results. The threshold line was set in the linear region of the plots above 
the baseline noise, and threshold cycle (Ct) values were determined as the cycle number 
at which the threshold line crossed the amplification curve. Ovine TUB was used as the 
reference gene. The relative quantification of gene expression across treatments was 
evaluated by using the comparative CT method as previously described [142].   
 
Table 3.1. Primer Sequences for Real-Time Quantitative PCR 
Gene 
Symbol 
Gene Name Accession 
Number 
Primer Sequence 
5' to 3' 
AGR2 Anterior 
Gradient 
Homolog 2 
NM_001040500 For: 
CCTCTCTCCTGATGGCCAGTAT 
 
Rev: 
CAGTCAGGGATGGGTCAACAA 
CDX2 Caudal Type 
Homeobox 2 
XM_004012288
.1 
 
For: GGGCCCCAAGTGAAAACC 
 
Rev: ACGCTGGTGGTCGGTGTA 
RUVBL2 Reptin AF155138 For: GCTTGGTGTGCCGGAAAC 
 
Rev: CCCGCTTGATGTCATCCA 
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In Situ Hybridization Analysis 
 Localization of AGR2 mRNAs in the ovine uterus and placentomes were 
determined by radioactive in situ hybridization as described previously [143]. 
Radiolabeled antisense and sense cRNA probes were generated by in vitro transcription 
using linearized partial plasmid cDNA templates, RNA polymerases and [α-35S]UTP. 
Deparaffinized, rehydrated, and deproteinated uterine tissue sections were hybridized 
with radiolabeled antisense or sense cRNA probes. After hybridization, washing, and 
ribonuclease A digestions, slides were dipped in NTB-2 liquid photographic emulsion 
(Kodak, Rochester, NY) and exposed at 4C for 4 to 6 weeks. Slides were developed in 
Kodak D-19 developer, counterstained with Gill's hematoxylin (Fisher Scientific, 
Pittsburgh, PA) and then dehydrated through a graded series of alcohol to xylene. 
Coverslips were then affixed with Permount (Fisher). Images of representative fields 
were recorded under brightfield or darkfield illumination using a Nikon Eclipse 1000 
photomicroscope (Nikon Instruments Inc., Lewisville, TX) fitted with a Nikon 
DXM1200 digital camera. 
Western Blot Analysis 
 Protein content of concentrated flushes were determined using a Bradford protein 
assay (Bio-Rad, Hercules, CA) with BSA as the standard. Thirty micrograms of uterine 
flush proteins were denatured and separated by 15% SDS-PAGE and transferred to 
nitrocellulose as described previously[144].  Western blot analyses were conducted as 
described previously[145]. Blots were incubated with primary antibody overnight at 4 C, 
rinsed for 30 minutes at room temperature with TBST, incubated with the appropriate 
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peroxidase-conjugated secondary antibody for 1 hour at room temperature, and then 
rinsed again for 30 minutes at room temperature with TBDT. Immunoreactive proteins 
were detected using enhanced chemilluminescence (Amhersham Pharmacia Biotech) 
according to the manufacturer's recommendations.  Immunoreactive AGR2 was detected 
using anti-AGR2 antibody produced in rabbit (Sigma-Aldrich, St. Louis.MO) at a 1:250 
dilution. 
Statistical Analysis 
 Regression analyses were conducted using the PROC-MIXED procedures of the 
Statistical Analysis System (SAS Institute, Cary, NC), as described previously [9]. All 
other measures were subjected to least-squares analysis of variance using the General 
Linear Models procedures of the Statistical Analysis System.  Data are presented as the 
least-squares means with overall standard error of the mean (SE).  There was no effect of 
fetal sex in the statistical model therefore it was removed.  Differences in means were 
considered to be statistically significant when a P value was ≤0.05 while a P value of 
≤0.1 was considered to indicate a tendency toward significance.  
Results 
Early Pregnancy     
 To determine temporal and spatial changes in expression of AGR2 mRNAs 
during ovine pregnancy we conducted in situ hybridization on endometrial sections on 
days 10 through 16 of the estrous cycle and days 10 through 20 of pregnancy.  AGR2 
mRNA is low to undetectable on day 10 of cyclicity and pregnancy. Its expression which 
is primarily localized to the LE and sGE increases to day 12 of cyclicity and pregnancy. 
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Interestingly, AGR2 mRNA expression is greater on day 14 of pregnancy than the cycle 
and this continues to day 16 with expression detectable in the middle GE as well. AGR2 
mRNA expression remains abundant on days 18 and 20 of pregnancy, but is not present 
in the elongating conceptus on these days (Figure 3.2). To determine protein 
quantification during early pregnancy AGR2 (22 kDa) was detected in uterine flushings 
recovered from ewes on days 10, 12, 14, and 16 post estrus (Figure 3.3). AGR2 exhibits 
an effect by day and pregnancy status. AGR2 protein significantly increases on day 14 
and 16 of pregnancy compared to cyclic ewes (P<0.001).  
 Because AGR2 mRNA and protein expression were upregulated in the presence 
of an elongating conceptus we next investigated the effects of individual conceptus 
products on the regulation of AGR2 mRNA expression. Results indicate that infusion of 
PG, CORT, or IFNT alone did not increase endometrial AGR2 mRNA expression, 
however, when PG and CORT, CORT and IFNT, or PG and IFNT were administered in 
combination, AGR2 mRNA expression increased to levels observed in control day 14 
pregnant ewes (P<0.05) (Figure 3.4).  
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Figure 3.2. In situ localization of AGR2 mRNA in the cyclic and early pregnant ovine 
uterus. Cross-sections of the uterus were hybridized with radiolabeled antisense or sense 
cRNA probes and digested with Rnase A. Protected transcripts were visualized by liquid 
emulsion autoradiography. Developed slides were counterstained lightly with 
hematoxylin, and photomicrographs recorded under bright-field  or dark-field 
illumination. Legend: GE, glandular epithelium; LE, luminal epithelium; S, stroma; Tr, 
trophectoderm; BV, blood vessels. 
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Figure 3.3. (A) Effect of day and pregnancy status on levels of AGR2 protein detected 
in uterine flushes. Flushes were recovered from ewes on days 10, 12, 14, and 16 post-
estrus as measured by Western blot. Differences (P < .001) are denoted with an asterisk 
(*). (B) Quantification of blot density.  
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Figure 3.4. Effects of intrauterine treatment on expression of AGR2 mRNA in the 
endometrium of cyclic sheep. Cyclic ewes received intrauterine infusions of vehicle as a 
CX, CORT (cortisol), PG (prostaglandin), CORT and PG, recombinant ovine IFNT, or 
IFNT and PG from day 10 to day 14 after estrus. Endometrial mRNA abundance was 
measured by real-time PCR and expressed as fold change relative to CX ewes. 
Differences (P < .05) are denoted with an asterisk (*) for the different treatments 
determined by orthogonal contrast.  
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Late Pregnancy 
 The role of AGR2 in ovine late pregnancy was also investigated. In situ 
hybridization was used to localize AGR2 mRNA in the both the placentome and 
intercaruncular endometrium during pregnancy. During late gestation (study 3)  AGR2 
mRNA was detected in the stratum compactum and GE of the uterine endometrium and 
this expression pattern remains present through Day 120 of pregnancy (Figure 3.5). In 
the placentome, real-time PCR confirmed AGR2 expression throughout the time course 
of pregnancy (Day 50, 75, 100, and 125) in both adequately fed and nutrient restricted 
ewes (Figure 3.6). In situ hybridization showed AGR2 mRNA is abundantly expressed in 
the caruncular crypts of the placentome  (Figure 3.7).  
Additionally, downstream targets of AGR2 were evaluated in the ovine 
placentome. Reptin, recently validated as an interacting protein with AGR2 in human 
cells plays a role in driving the stability of the AGR-reptin complex[110]. Reptin 
expression did not differ on Days 50 and 75 of gestation, however, Reptin expression 
was lower in placentomes from adequately fed ewes on Day 125 of pregnancy compared 
to Day 100. This can be compared to Reptin expression found in the placentomes from 
nutrient restricted ewes which remained elevated on Day 125 (Figure 3.8). Additionally, 
CDX2 (caudal related homeobox 2) is also found to be an interacting factor with AGR2. 
CDX2 is known to regulate trophectoderm differentiation as well as the trophoblast 
specific gene interferon tau (IFNT) in ruminants[117]. Thus, CDX2 was also evaluated 
in the ovine placentome throughout the described time course of pregnancy. CDX2 
expression was reduced in the ewes receiving 100% NRC compared to the 50% NRC 
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fed ewes on day 50 of pregnancy (P<0.05). Specifically, CDX2 expression in 
placentomes of nutrient restricted ewes decreased on Day 125 compared to expression 
levels on Days 50 and 75. CDX2 levels increased between days 50 to 100 and then 
decreased between days 100 to 125 (Figure 3.9).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. In situ localization of AGR2 mRNA in the ovine uterus of pregnant ewes 
days of late pregnancy. Cross-sections of the uterus were hybridized with radiolabeled 
antisense or sense cRNA probes and digested with Rnase A. Protected transcripts were 
visualized by liquid emulsion autoradiography. Developed slides were counterstained 
lightly with hematoxylin, and photomicrographs recorded under bright-field  or dark-
field illumination. Legend: GE, glandular epithelium; LE, luminal epithelium 
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Figure 3.6. Steady state mRNA levels of AGR2 in the ovine placentome throughout the 
time course of pregnancy. Ewes received either 100% NRC or 50% NRC on days 50, 75, 
100, and 125 gestation. No significant changes were observed in AGR2 expression 
regardless of day and nutrient status. 
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Figure 3.7. In situ localization of AGR2 mRNA in the ovine placentome days of late 
pregnancy. Cross-sections of the placentome were hybridized with radiolabeled 
antisense or sense cRNA probes and digested with Rnase A. Protected transcripts were 
visualized by liquid emulsion autoradiography. Developed slides were counterstained 
lightly with hematoxylin, and photomicrographs recorded under bright-field  or dark-
field illumination. Legend: COT, Cotyledon; CAR, Caruncle.  
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Figure 3.8. Steady state mRNA levels of Reptin in the ovine placentome throughout the 
time course of pregnancy. Ewes received either 100% NRC or 50% NRC on days 50, 75, 
100, and 125 gestation. No significant changes were observed in Reptin expression on 
days 50 and 75. However, Reptin expression decreased in the adequately fed ewes on 
days 125 compared to day 100. Reptin expression remained elevated in the nutrient 
restricted ewes on day 125 gestation 
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Figure 3.9. Steady state mRNA levels of CDX2 in the ovine placentome throughout the 
time course of pregnancy. Ewes received either 100% NRC or 50% NRC on days 50, 75, 
100, and 125 gestation. On day 50 CDX2 expression was significantly lower in the 
placentomes of the adequately fed ewes compared to the nutrient restricted ewes. 
Expression of CDX2 decreased on day 125 compared to expression levels seen on day 
50 and 75 in the nutrient restricted ewes. Conversely, CDX2 expression increased from 
day 50 to 100 and decreased from day 100 to 125 in the 100% NRC fed ewes. 
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Using the model previously described by Dunlap et al. a study was completed  to 
identify a population of IUGR and non-IUGR offspring from a similar cohort of 
nutrient-restricted ewes as a first step to assess adaptive mechanisms of placental 
nutrient transport [9]. This study tested the hypothesis that maternal nutrient restriction 
results in differential or adaptive placental transport of critical nutrients resulting in both 
IUGR and non-IUGR offspring[9]. Therefore, this study utilized an Affymetrix 
Bovine/Ovine Gene 1.0 ST array to capitalize on natural population variance in response 
to nutrient restriction and to identify novel factors regulating placental function and fetal 
growth. AGR2 was among the novel genes identified to be differentially expressed by 
the  microarray. Steady state mRNA levels of AGR2 were reduced (P<0.05) in 
placentomes from NR ewes producing non-IUGR fetuses compared to NR ewes 
producing IUGR fetuses (Figure 4.1).  In situ hybridization showed localization of AGR2 
mRNA in the placentome. Control fed ewes as well as NR IUGR exhibited abundant 
expression of AGR2 while AGR2 expression lessens and is more diffuse in the NR non-
IUGR placentome (Figure 4.2). Additionally genes known to interact with AGR2 were 
also evaluated using this research model. It was found that Reptin expression in the 
placentome at day 125 gestation was higher (P<0.05) in the NR non-IUGR compared to 
the NR IUGR (Figure 4.3). CDX2 expression had a tendency to follow this same pattern 
in which expression is higher in the NR non-IUGR compared to the NR IUGR (P<0.1) 
(Figure 4.4). 
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Figure 4.1. Steady state mRNA levels of AGR2 in the ovine placentome of nutritionally 
manipulated ewes.  Levels of AGR2 were reduced(P<0.05) in placentomes from ewes 
producing NR non-IUGR fetuses compared to placentomes from ewes producing NR 
IUGR fetuses.   
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Figure 4.2. In situ localization of AGR2 mRNA in the ovine placentome of nutritionally 
manipulated ewes. Cross-sections of the placentome were hybridized with radiolabeled 
antisense or sense cRNA probes and digested with Rnase A. Protected transcripts were 
visualized by liquid emulsion autoradiography. Developed slides were counterstained 
lightly with hematoxylin, and photomicrographs recorded under bright-field  or dark-
field illumination. Legend: COT, Cotyledon; CAR, Caruncle 
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Figure 4.3. Steady state mRNA levels of Reptin in the ovine placentome of nutritionally 
manipulated ewes.  Levels of Reptin were reduced(P<0.05) in placentomes from ewes 
producing NR IUGR fetuses compared to placentomes from ewes producing NR Non-
IUGR fetuses.   
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Figure 4.4. Steady state mRNA levels of CDX2 in the ovine placentome of nutritionally 
manipulated ewes. Levels of CDX2  had a tendency to be  reduced (P<0.1) in 
placentomes from ewes producing NR IUGR fetuses compared to placentomes from 
ewes producing NR Non-IUGR fetuses.   
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Discussion 
 Results of the present study include examination of the AGR2 pathway in the 
ovine uterus and placenta throughout gestation in order to establish temporal and spatial 
expression. These studies provide a platform for which future mechanistic studies to 
examine function can be designed. Results demonstrate AGR2 to be hormonally 
regulated at the level of the CL and by conceptus derived products secreted into the 
uterine lumen suggesting a role in migration, proliferation and growth of the conceptus. 
Additionally, Hong et al., found AGR2 contributed to growth and angiogenesis in 
glioblastomas[146]. Recombinant AGR2 was found to induce human umbilical vein 
endothelial cell (HUVEC) migration and tube formation, this affect was abrogated by 
anti-AGR2 neutralizing antibodies[146]. Thus, these findings indicate AGR2 is a 
proliferative agent that stimulates angiogenesis. These known functions are critical for 
pregnancy success which suggests AGR2 could have similar actions on the conceptus. 
Further studies analyzing AGR2's role in growth and interaction with the conceptus are 
needed. 
 In order to determine spatial and temporal changes in AGR2 expression, 
representative photomicrographs of in situ hybridization in cyclic and pregnant uterine 
tissue indicate that AGR2 mRNA expression in the LE, sGE, and middle GE increases 
from day 14 to 20 of early pregnancy. Interestingly, AGR2 mRNA is not detected in the 
early elongating conceptus. Results further demonstrate that cyclic ewes receiving 
combined intrauterine infusions of conceptus derived hormones increases endometrial 
expression AGR2 mRNA. Collectively, results of the present studies coupled with 
 68 
 
previously published data indicate that endometrial AGR2 expression is acutely 
controlled by both ovarian and conceptus derived hormones to alter the uterine milieu 
during early pregnancy. It is well established that blastocyst growth and development 
into an elongated conceptus is critical for pregnancy recognition and implantation in 
ruminants[147]. Migration ultimately allows for more equitable allocation of uterine 
resources and elongation ensures increased surface area of the uterus available to the 
conceptus for interactions that support pregnancy [148]. Furthermore AGR2 has 
garnered major scientific interest in regards to cancer and tumor development. Recent 
cell culture experiments have demonstrated that when cultured under serum depleted 
conditions and/or hypoxia, AGR2 was activated to promote angiogenesis, motility and 
invasion[121]. AGR2 thus may have similar roles in stimulating growth and 
development of the conceptus which is critical for pregnancy success. Elucidating the 
exact role of AGR2 in regulating and/or stimulating conceptus development is of critical 
importance. 
                Using the model previously described to investigate adaptive mechanisms of 
placental nutrient transport in both IUGR and non-IUGR offspring, AGR2 was found as 
a differentially expressed gene potentially necessary in adaptive placental development. 
AGR2 is induced by various stresses such as hypoxia, serum depletion and ER stress 
[149]. Ewes that experienced nutrient restriction induced stress and subsequently 
produced IUGR offspring showed elevated placentomal levels of AGR2. These findings 
indicate, NR ewes that produce normal fetal weight offspring may, through reduced 
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levels of AGR2, exhibit an adaptive placental response to maximize fetal growth in 
response to stress.    
 Although mainly localized in the endoplasmic reticulum, AGR2 has the ability to 
play other intracellular roles such as inducing EGF receptor ligand amphiregulin 
(AREG)[105], interacting with AAA+ protein Reptin [110], and has also been linked 
with the expression of the transcription factor caudal related homeobox 2 (CDX2)[100].    
Recently, a protein named Reptin was identified as an AGR2 binding protein in a yeast 
two-hybrid screen and was validated as an interacting protein with AGR2 in human cells 
[110]. Reptin belongs to a family of proteins known as AAA+ATPases (ATPases 
associated with various cellular activity) [111]. AGR2 uses a divergent-binding loop to 
bind to Reptin and then Reptin uses two allosterically interacting ATP binding motifs to 
control its binding activity toward AGR2[110]. Real- time PCR confirmed Reptin 
expression in the placentome throughout the time course of pregnancy. However, its 
expression pattern differed from that observed for AGR2 indicating Reptin is not a 
downstream product of AGR2 signaling in the sheep placentome. 
Additional studies have also linked AGR2 with the expression of the transcription factor 
caudal related homeobox 2 (CDX2). The induction of CDX2 expression by AGR2 
stimulation is interesting from a reproductive context because CDX2 regulates 
trophectoderm differentiation as well as the trophoblast specific gene interferon tau 
(IFNT) in ruminants  [116]. CDX2 is isolated to the trophectoderm and is essential for 
ensuring correct segregation of the Inner Cell Mass and Trophectoderm cell lineages in 
blastocysts as CDX2 ensures the repression of Oct4 and Nanog in the trophectoderm 
 70 
 
[119]. Specifically, CDX2 has been detected in day 15 and 17 ovine conceptuses [150] 
and is involved in histone modifications of the IFNT gene [118]. Thus as a downstream 
target of AGR2, CDX2 may play a role in placental function and conceptus 
development.  Interestingly, CDX2 expression mirrored the pattern of AGR2 expression 
in the adequately fed ewes. Expression pattern, however, was markedly different in the 
nutrient restrict (50% NRC) fed ewes, indicating CDX2 expression is most likely 
differentially regulated in the cases of gestational nutrient restriction.   Results of the 
present study demonstrate localization for AGR2 during various stages of pregnancy in 
the ewe. Collectively, results suggest that AGR2 is regulated at the level of the CL and 
by conceptus derived products in early pregnancy. In nutrient scarce conditions a 
reduction in AGR2 may be necessary for enhanced placental function. Additionally, by 
analyzing genetic downstream targets of AGR2 we have found that Reptin and CDX2 
may also play a role in stimulating placental function however it is not clear whether 
these genes are fully or partially regulated by AGR2. This study is foundational in 
establishing AGR2 as a relevant factor throughout gestation, still future research is 
needed to further evaluate the mechanisms by which AGR2 plays a role in ovine 
pregnancy. 
 
 
 
 
 
 71 
 
CHAPTER IV 
SUMMARY AND DIRECTION OF FUTURE RESEARCH 
 
 Extensive study has been conducted regarding AGR2's regulation of tumor 
development. Pregnancy can be likened to the hypoxic conditions necessary to facilitate 
tumor growth. However, to our knowledge, this study is the first to evaluate the 
expression and regulation of AGR2 in ovine pregnancy. Collectively, results suggest 
AGR2 is likely to play a role in conceptus development and endometrial function. In 
nutrient scarce conditions a reduction in the proliferative actions of AGR2 may be 
necessary for enhanced placental function. This novel finding has potential in further 
understanding the developmental events necessary for embryonic survival as well 
features that govern pregnancy success throughout gestation. Future studies will be 
needed to further evaluate the signaling cascades elicited by this gene and continue to 
define the role of AGR2 throughout pregnancy. 
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